Fyodor Urnov at an internal event at the University of California, Berkeley’s Innovative Genomics Institute (Credit: Diego Moran/UC Berkeley)
July 8, 2025 03:59 PM EDT
R&D
Cell/Gene Tx

'CRISPR Cures' cen­ter launch­es with $20M to make cus­tomized gene edit­ing ther­a­pies

Ryan Cross

Senior Science Correspondent

Sci­en­tists seek­ing to make per­son­al­ized gene edit­ing ther­a­pies a re­al­i­ty for more peo­ple have launched a new ini­tia­tive to de­vel­op cures for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­phar­ma's 20 high­est-paid CEOs of 2024 with $20M+ pay­days

Trump hints at tar­iff grace pe­ri­od for phar­ma com­pa­nies to bring man­u­fac­tur­ing to US

ProKid­ney's stock shoots high­er af­ter mixed Phase 2 da­ta

Shell com­pa­ny Con­cen­tra has found its rhythm, with Car­go Ther­a­peu­tics as its lat­est buy­out tar­get

Ot­su­ka’s Tai­ho re­ports Phase 3 fail for Duchenne mus­cu­lar dy­s­tro­phy drug

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times